MDMA (ecstasy) effects in pubescent rats: Males are more sensitive than females

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 3, 2005, Pages 635-644

  Koenig, Julie ^a   Lazarus, Christine ^a   Jeltsch, Hélène ^a   Hamida, Sami Ben ^a   Riegert, Céline ^a   Kelche, Christian ^a   Jones, Byron C ^b   Cassel, Jean Christophe ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Ecstasy; Lethality; Locomotor activity; MDMA; Pubescence; Sexual dimorphism

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BIOLOGICAL MARKER; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; BRAIN CORTEX; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; DRUG FATALITY; FEMALE; HIPPOCAMPUS; HYPERACTIVITY; LETHALITY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PUBERTY; RAT; RAT STRAIN; ROOM TEMPERATURE; SEROTONIN RELEASE; SEX DIFFERENCE;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BODY TEMPERATURE; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYDROXYINDOLEACETIC ACID; MALE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NOREPINEPHRINE; RANDOM ALLOCATION; RATS; RATS, LONG-EVANS; SEROTONIN; SEX FACTORS; SEXUAL MATURATION; SURVIVAL RATE; TIME FACTORS;

EID: 22044431879     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.04.014     Document Type: Article

References (43)

1. S.L. Andersen, M. Rutstein, J.M. Benzo, J.C. Hostetter, and M.H. Teicher Sex differences in dopamine receptor overproduction and elimination Neuroreport 8 1997 1495 1498
2. S.L. Andersen, A.P. Thompson, E. Krenzel, and M.H. Teicher Pubertal changes in gonadal hormones do not underlie adolescent dopamine receptor overproduction Psychoneuroendocrinology 27 2002 683 691
3. H.C. Atkinson, and B.J. Waddell Circadian variation in basal plasma corticosterone and adrenocorticotropin in the rat: sexual dimorphism and changes across estrous cycle Endocrinology 138 1997 342 348
4. G. Battaglia, B.P. Brooks, C. Kulsakdinun, and E.B. De Souza Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites Eur J Pharmacol 149 1988 159 163
5. V. Bisagno, D. Ferguson, and V.N. Luine Chronic d-amphetamine induces sexually dimorphic effects on locomotion, recognition memory, and brain monoamines Pharmacol Biochem Behav 74 2003 859 867
6. H.W. Broening, J.F. Bowyer, and W. Slikker Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (±)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response J Pharmacol Exp Ther 275 1995 325 333
7. J.D. Cadet, B. Ladenheim, I. Baum, E. Carlson, and C. Epstein CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA) Brain Res 655 1994 259 262
8. S. Cailhol, and P. Mormede Strain and sex differences in the locomotor response and behavioral sensitization to cocaine in hyperactive rats Brain Res 842 1999 200 205
9. T. Chu, Y. Kumagai, E.W. DiStefano, and A.K. Cho Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion Biochem Pharmacol 51 1996 789 796
10. M.I. Colado, J.L. Williams, and A.R. Green The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype Br J Pharmacol 115 1995 1281 1289
11. W.R. Crowley, T.L. O'Donohue, and D.M. Jacobowitz Sex differences in catecholamine content in discrete brain nuclei of the rat: effects of neonatal castration or testosterone treatment Acta Endocrinol (Copenh) 89 1978 20 28
12. R.I. Dafters, and S.M. Biello The effect of 3,4- methylenedioxymethamphetamine ('Ecstasy') on serotonergic regulation of the mammalian circadian clock mechanism in rats: the role of dopamine and hyperthermia Neurosci Lett 350 2003 117 121
13. R. De la Torre, and M. Farré Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans TIPS 25 2004 505 508
14. G.J. De Vries Sex differences in neurotransmitter systems J Neuroendocrinol 2 1990 1 13
15. N. Easton, J. Fry, E. O'Shea, A. Watkins, S. Kingston, and C.A. Marsden Synthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy) Brain Res 987 2003 144 154
16. K.C.F. Fone, S.R.G. Beckett, I.A. Topham, J. Swettenham, M. Ball, and L. Maddocks Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic toxicity Psychopharmacology 159 2002 437 444
17. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'Shea, and M.I. Colado The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") Pharmacol Rev 55 2003 463 508
18. 1 receptors in rats Eur J Pharmacol 445 2002 97 104
19. D. Howell Statistical Methods for Psychology 1997 Duxburry Press Belmont
20. E.A. Johnson, J.P. O'Callaghan, and D.B. Miller Brain concentrations of d-MDMA are increased after stress Psychopharmacology 173 2004 278 286
21. J.H. Kehne, H.J. Ketteler, T.C. McCloskey, C.K. Sullivan, M.W. Dudley, and C.J. Schmidt Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats Neuropsychopharmacology 15 1996 116 124
22. J.E. Malberg, and L.S. Seiden Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat J Neurosci 18 1998 5086 5094
23. A.O. Mechan, B. Esteban, E. O'Shea, J.M. Elliott, M.I. Colado, and A.R. Green The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats Br J Pharmacol 135 2002 170 180
24. D.B. Miller, and J.P. O'Callaghan The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine Mol Neurobiol 11 1995 177 192
25. J. Mordanti, and W. Chappell The use of interspecies scaling in toxicokinetics A. Yacogi J. Kelly V. Batra Toxicokinetics and new drug development 1989 Pergamon Press New York 42 96
26. S. Morley-Fletcher, M. Bianchi, G. Gerra, and G. Laviola Acute and carryover effects in mice of MDMA (ecstasy) administration during adolescence Eur J Pharmacol 448 2002 31 38
27. S. Morley-Fletcher, M. Puopolo, S. Gentili, G. Gerra, T. Macchia, and G. Laviola Prenatal stress affects 3,4-methylenedioxymethamphetamine pharmacokinetics and drug-induced motor alterations in adolescent female rats Eur J Pharmacol 489 2004 89 92
28. E.D. O'Loinsigh, G. Boland, J.P. Kelly, and K.M. O'Boyle Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat Prog Neuropsychopharmacol Biol Psychiatry 25 2001 621 638
29. A.C. Parrott Chronic tolerance to recreational MDMA (3,4- methylenedioxymethamphetamine) or ecstasy J Psychopharmacol 19 2005 71 83
30. W. Pedersen, and A. Skrondal Ecstasy and new patterns of drug use: a normal population study Addiction 94 1999 1695 1706
31. B.J. Piper, and J.S. Meyer Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period Pharmacol Biochem Behav 79 2004 723 731
32. I. Reisert, J. Engele, and C. Pilgrim Early sexual differentiation of diencephalic dopaminergic neurons of the rat in vitro Cell Tissue Res 255 1989 411 417
33. L. Reneman, J. Booij, K. de Bruin, J.B. Reitsma, F.A. de Wolff, and W.B. Gunning Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons Lancet 358 2001 1864 1869
34. P. Restani, E. Corsini, R. Galimberti, and C.L. Galli Postnatal ontogenesis of dopaminergic and serotoninergic systems in rat caudate nucleus Pharmacol Res 22 1990 343 350
35. S.C. Riley, C. James, D. Gregory, H. Dingle, and M. Cadger Patterns of recreational drug use at dance events in Edinburgh, Scotland Addiction 96 2001 1035 1047
36. K.E. Sabol, R. Lew, J.B. Richards, G.L. Vosmer, and S.L. Seiden Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period: Part I. Synaptosomal uptake and tissue concentrations J Pharmacol Exp Ther 276 1996 846 854
37. F. Schifano A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities Psychopharmacology 173 2004 242 248
38. C.W. Schindler, and G.N. Carmona Effects of dopamine agonists and antagonists on locomotor activity in male and female rats Pharmacol Biochem Behav 72 2002 857 863
39. N.G. Simon, and R.P. Mattick The impact of regular ecstasy use on memory function Addiction 97 2002 1523 1529
40. I. Weiner, G. Gal, J.N. Rawlins, and J. Feldon Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity Behav Brain Res 81 1996 123 133
41. A.R. Winstock, K. Wolff, and J. Ramsey Ecstasy pill testing: harm minimization gone too far? Addiction 96 2001 1139 1148
42. J.L. Yau, J. Noble, and J.R. Seckl Site-specific regulation of corticosteroid and serotonin receptor subtype gene expression in the rat hippocampus following 3,4-methylenedioxymethamphetamine: role of corticosterone and serotonin Neuroscience 78 1997 111 121
43. W. Zhou, K.A. Cunningham, and M.L. Thomas Estrogen effects on the hyperactivity induced by (+)-MDMA and cocaine in female rats Behav Neurosci 117 2003 84 94